Skip to main content
logo
Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
16.40
+0.50 (3.14%)
At close: Aug 10, 2026, 4:00 PM EDT
16.39
-0.01 (-0.06%)
Pre-market: Aug 11, 2026, 8:44 AM EDT

Beta Bionics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
119.01100.2565.12120.18
Revenue Growth
52.54%53.94%442.93%6601.12%-
Cost of Revenue
49.6144.7129.245.69-
Gross Profit
69.455.5435.896.310.18
Selling, General & Admin
113.592.4354.9624.2234.6
Research & Development
38.9234.7926.1817.9431.43
Total Operating Expenses
152.42127.2281.1442.1666.02
Operating Income
-83.02-71.68-45.25-35.85-65.84
Interest Income
10.0410.933.911.780.2
Interest Expense
-----0.01
Other Non-Operating Income (Expense)
2.38-12.45-13.41-10.030.91
Total Non-Operating Income (Expense)
12.42-1.52-9.51-8.251.09
Pretax Income
-70.6-73.2-54.76-44.1-64.75
Net Income
-72.97-73.2-54.76-44.1-64.75
Net Income to Common
-72.97-73.2-54.76-44.1-64.75
Net Income Growth
-----
Shares Outstanding (Basic)
4441655
Shares Outstanding (Diluted)
4441655
Shares Change
102.23%536.74%20.01%6.13%-
EPS (Basic)
-1.65-1.81-8.60-8.31-12.96
EPS (Diluted)
-1.65-1.81-8.60-8.31-12.96
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-61.41-56.22-51.67-32.85-60.98
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.39-1.39-8.12-6.19-12.20
Gross Margin
58.31%55.40%55.11%52.59%100.00%
Operating Margin
-69.75%-71.50%-69.48%-298.88%-36784.40%
Profit Margin
-61.32%-73.02%-84.08%-367.64%-36173.70%
FCF Margin
-51.60%-56.08%-79.34%-273.84%-34067.00%
EBITDA
-80.8-70.11-44.1-34.62-64.5
EBITDA Margin
-67.89%-69.93%-67.72%-288.65%-36033.00%
EBIT
-83.02-71.68-45.25-35.85-65.84
EBIT Margin
-69.75%-71.50%-69.48%-298.88%-36784.40%
SEC Filings: 10-K · 10-Q